Preventing tumour recurrence
For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence, and living with uncertainty is never easy. Discovering an intervention that can prevent cancer recurrence has the potential to significantly enhance quality of life.

Fighting the main threat: metastasis
Evidence is occasionally discovered supporting various, often simple interventions that improve existing treatment protocols. These additional therapies prevent tumour recurrence and contribute significantly to better outcomes. With 90% of deaths resulting from tumour recurrence and metastasis, primary tumours are not the main threat. While the mechanism of action of several interventions are not yet fully understood, research indicates that their influence on dormant cancer cells and the body’s own cancer-fighting mechanisms are at the core of their potential.
Our trials in this focus area
- Digestive cancer
- Breast cancer
Notre focus actuel
-
Le repositionnement des médicaments
[en anglais] Drug repurposing, also known as drug repositioning, is a drug development strategy predicated on the reuse... -
Les cancers moins courants et rares
[en anglais] We don’t just focus on the ‘big four’ of cancer – prostate, colon, breast and lung. We also investigate... -
Thérapies combinées
[en anglais] It is important to investigate the impacts of drugs beyond what they can achieve alone. Using them in... -
Prévenir la récidive des tumeurs
[en anglais] For cancer survivors, the fight isn’t always over. Many are concerned about the possibility of recurrence...
NOTRE PROMESSE
-
Nous investissons dans la recherche scientifique la plus prometteuse pour réaliser des progrès certains dans la lutte contre le cancer.
-
Améliorer et prolonger la vie des patients est notre seule cible. Le retour financier ne fait pas partie de nos objectifs.
-
Nous identifions des potentiels inexploités dans la recherche sur le cancer qui amèneront des solutions pragmatiques pour les patients dans le besoin.
-
Nous cherchons à obtenir un impact et pour ce faire, nous investissons nos ressources là où nous pensons pouvoir réaliser rapidement des progrès.
-
Chaque cancer mérite la même attention, indépendamment de critères de prévalence ou de rentabilité.